Mistletoe-Drug Interactions Will Be Subject Of NCCAM Intramural Study
This article was originally published in The Tan Sheet
The National Center for Complementary & Alternative Medicine's intramural division plans to study potential interactions between mistletoe and the cancer drug gemcitabine (Eli Lilly's Gemzar)
You may also be interested in...
NCCAM's Division of Intramural Research is composing study protocols to look at DHEA's effect on age-related health defects, Clinical Director Marc Blackman, MD, said at an advisory council meeting in Bethesda, Md. May 31.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning